OakChart

cbdMD Inc

YCBDHealthcare·Drug Manufacturers - Specialty & Generic·USA·Nano·AMEX·Nov 11 • 3:59 PM ET

0.3950+0.0113 (2.95%)
2026-11-12 01:20 CET
Market cap
4.30 USD m
Revenue, TTM
20.93 USD m
Net income, TTM
-3.08 USD m
Free cash flow, TTM
-2.41 USD m
EPS diluted, TTM
-0.31
P/E
-
Compare

Price

YCBD against its 20, 50 and 200-day averages
2050200miss
0.400.600.804.3M8.5MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26YCBDclose 0.4020-day 0.3850-day 0.42200-day 0.650.4052w low

84.6% under the 52-week high of 2.56 on 18 Dec 2025. 52-week low 0.33 on 13 Oct 2026. Last 15 sessions, 31.5% high to low

Volume 0.07× normal · the line is the 50-bar volume average

Profile

YCBD
52-week range, 3% of the way up
0.332.56

cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. Its product categories include CBD tinctures, gummies, topical, and bath bombs. The company was founded on March 17, 2015 and is headquartered in Charlotte, NC.

Employees42
IPONov 17, 2017
Beta2.36
ATR, 14d0.03
Rel volume0.07
Short float4.79%
Insider own10.13%
Inst own7.86%

Snapshot

6 groups

Valuation

Index-
Market Cap4.43M
Enterprise Value4.52M
Income-3.08M
Sales20.93M
Book/sh0.74
Cash/sh0.19
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees42
IPONov 17, 2017

Ratios

P/E-
Forward P/E-
PEG-
P/S0.21
P/B0.53
P/C2.09
P/FCF-
EV/EBITDA-
EV/Sales0.22
Quick Ratio1.37
Current Ratio2.50
Debt/Eq0.27
LT Debt/Eq0.23
Option/ShortNo / Yes

Earnings

EPS (ttm)-0.31
EPS next Y-0.19
EPS next Q-0.09
EPS this Y69.72%
EPS next Y42.42%
EPS next 5Y-
EPS past 3/5Y86.54% -
Sales past 3/5Y-18.46% -14.45%
EPS Y/Y TTM95.01%
Sales Y/Y TTM10.01%
EPS Q/Q46.87%
Sales Q/Q20.56%
EarningsAug 13 AMC
EPS/Sales Surpr.-266.67% -2.38%

Ownership

Insider Own10.13%
Insider Trans0.00%
Inst Own7.86%
Inst Trans-1.42%
ROA-25.07%
ROE-40.33%
ROIC-28.69%
Gross Margin52.81%
Oper. Margin-13.87%
Profit Margin-14.71%
SMA203.57%
SMA50-6.39%
SMA200-38.98%
Trades-

Technical

Shs Outstand11.12M
Shs Float10.07M
Short Float4.79%
Short Ratio1.26
Short Interest0.48M
52W High2.56 -84.57%
52W Low0.33 19.70%
Volatility9.39% 9.49%
ATR (14)0.03
RSI (14)49.24
Beta2.36
Rel Volume0.07
Avg Volume384.09K
Volume25,454

Performance

Perf Week-2.71%
Perf Month11.27%
Perf Quarter-30.09%
Perf Half Y-50.36%
Perf YTD-70.74%
Perf Year-50.87%
Perf 3Y-93.05%
Perf 5Y-99.94%
Perf 10Y-
Recom3.00
Target Price2.00
Prev Close0.38
Price0.40
Change %2.95%

Peers

Mkt cap
TickerCompanyMkt cap
IMCCIM Cannabis Corp0.95M
AKANAkanda Corp1.93M
TLRYTilray Brands Inc385.73M
CGCCanopy Growth Corp256.13M
CRONCronos Group Inc1.26B
MTRIMentari Therapeutics Inc8.57M
ACBAurora Cannabis Inc331.99M
OGIOrganigram Global Inc120.38M
GLASGlass House Brands Inc144.79M
GRWGGrowGeneration Corp74.24M

Insider trading

2 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Crosnoe Clark R.10% OwnerDec 17 '25Sale2.32550,7011,276,84217,875Dec 19 09:16 AM
Clark R. Crosnoe, CRC InvestmeStockholderDec 17 '25Proposed Sale2.25986,8512,220,415Dec 17 07:52 PM

Held by

AUM
TickerCompanyAUM
VXFVanguard Extended Market Index ETFAUM: 30.47B

News

latest 14 of 196
  • Reserveage Launches Longev+ Exclusively at The Vitamin Shoppe, Bringing Strength Into the Healthy Aging Conversation (PR Newswire)
  • cbdMD Enters Definitive Agreement to Acquire Twinlab Brands, Expanding Into Legacy Supplements, Sports Nutrition, Women's Beauty, Weight Loss and Longevity Wellness (PR Newswire)
  • cbdMD Inc (YCBD) (Q3 2026) Earnings Call Highlights: Strategic Pivot and Cost Cuts Aim to ... (GuruFocus.com) -12.26%
  • cbdMD Reports 20% Year-over-Year Revenue Growth for the Third Fiscal Quarter of 2026 (PR Newswire) -5.52%
  • cbdMD, Inc. to Host Conference Call to Discuss June 30, 2026, Third Quarter Results (PR Newswire)
  • cbdMD Applauds Proposed SENATE SPENDING BILL That Would Protect Access to Full-Spectrum CBD and Other Naturally Derived Hemp Products (PR Newswire) +12.35%
  • cbdMD Supports the Bipartisan Lawful Hemp Protection Act to Protect Consumers and Full-Spectrum CBD Access (PR Newswire) -6.65%
  • cbdMD's Oasis Brand Partners with Mexcor to Launch Into South Carolina (PR Newswire)
  • cbdMD's Bluebird Botanicals Announces Official Partnership With Denver Audubon to Support Bird Conservation (PR Newswire) +8.00%
  • cbdMD Sets a New Safety Standard for Broad Spectrum CBD With Self-Affirmed GRAS Determination (PR Newswire)
  • Oasis Launches Hemp-Derived Mixer (PR Newswire)
  • cbdMD Welcomes White House Call for Fair Treatment of Hemp-Derived Products (PR Newswire) +6.34%
  • cbdMD Appoints Wade Brown Chief Marketing Officer (PR Newswire)
  • cbdMD Inc (YCBD) Q2 2026 Earnings Call Highlights: Strong Sales Growth Amidst Regulatory Challenges (GuruFocus.com) -5.32%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-08-13-0.110-0.030-0.1105.555.691
2026Q22026-05-14-0.080-0.050-0.0845.645.291
2026Q12026-02-17-0.040-0.060-0.0365.024.861
2025Q42025-12-192.780-0.070-0.0764.724.701
2025Q32025-08-14-0.210-0.020-0.2134.615.301
2025Q22025-05-16-1.900-1.600-1.9034.755.141
2025Q12025-02-13-1.760--1.7325.11--
2024Q42024-12-18--3.600-2.346-4.811
2024Q32024-08-14-1.200-4.960-1.2045.174.931
2024Q22024-05-15-10.800-6.000-10.8374.385.401
2024Q12024-02-13-5.360-5.920-5.3965.385.801
2023Q42023-12-22-46.960-6.080-45.6015.716.131
2023Q32023-08-10-9.280--9.3156.12--
2023Q22023-05-15-13.920--13.8966.24--
2023Q12023-02-13-28.800--29.5636.09--
2021Q32021-08-12--5.72410.60--

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-914.4-916.8-1,01523.6525.01
2020FY100.8-10.80097.51041.8841.39
2021FY-169.2-133.2-170.0444.4845.94
2022FY-446.4-183.6-446.3735.4040.80
2023FY-106.56--106.5724.16-
2024FY-14.320-21.040-14.29219.4819.73
2025FY-1.090-1.080-1.08019.1919.17
2026FY--0.330--21.92
2027FY--0.190--28.60

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-10-281005.715.715.71
2026Q4S2026-09-031015.715.715.71
2026Q4S2026-09-021015.715.715.71
2026Q4S2026-08-141015.715.715.71
2026Q4S2026-08-131005.815.815.81
2026Q4S2026-07-291005.815.815.81
2026Q4S2026-05-151105.815.815.81
2026Q4S2026-05-041005.515.515.51
2026Q4S2026-02-181105.515.515.51
2026Q4S2025-12-231014.964.964.96
2026Q4S2025-11-111005.015.015.01
2026Q4S2025-11-101005.015.015.01
2026Q4S2025-11-091005.015.015.01
2026Q4S2025-11-081005.015.015.01

Estimate history

EPS, annual-80.262-19.159-1014.92397.51-170.042-446.371-106.572-14.292-1.088-0.3091
Period201720182019202020212022202320242025TTM
EPS, quarterly-1.204-2.346-1.732-1.903-0.213-0.076-0.036-0.084-0.113
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual4.4750.45923.65241.88444.48135.40324.15519.48219.1920.93
Period201720182019202020212022202320242025TTM
Sales, quarterly5.1744.5565.1134.7494.6074.7215.0175.645.554
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual0.0220.0230.0770.1450.1610.1690.370.4928.91711.119
Period201720182019202020212022202320242025MRQ
Shares, quarterly0.470.4920.6930.7838.9088.91710.07110.49611.119
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue20.9319.1919.4824.1635.4044.4841.8823.650.46
Cost of Goods Sold Incl. D&A9.888.358.6411.1214.9015.5115.519.140.33
Gross Profit11.0510.8410.8513.0420.5028.9726.3714.510.13
Selling, General and Administrative Excl. Other13.9613.0014.0422.3137.8148.5843.9528.881.93
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-2.90-2.16-3.19-9.27-17.31-19.62-17.58-14.36-1.80
Interest Expense--0.03--0.03-0.000.00
Unusual Expense0.00-0.090.4813.0353.085.22-29.0233.400.00
Net Income Before Taxes-2.89-2.04-3.70-22.94-70.08-24.2911.31-47.79-1.80
Income Taxes0.000.000.000.000.00-0.90-1.35-2.360.00
Consolidated Net Income-2.89-2.04-3.70-22.94-70.08-23.3912.65-45.43-1.80
Net Income From Continuing Operations-2.89-2.04-3.70-22.94-70.08-23.3912.65-45.43-1.80
Net Income-3.08-4.38-7.70-26.94-74.09-25.9512.24-50.43-0.41
EPS (Recurring)-0.29-1.10-13.67-70.48-222.49-146.09-64.38-544.36-19.16
EPS (Basic, Before Extraordinaries)-0.31-1.09-14.29-106.57-446.37-170.0499.79-1,014.92-19.16
EPS (Diluted)-0.31-1.09-14.29-106.57-446.37-170.0497.51-1,014.92-19.16
EBITDA-1.19-0.37-1.37-6.34-14.34-17.36-15.68-14.07-1.57
Non-Operating Income (Expense)0.020.030.00-0.640.310.58-0.13-0.030.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.370.010.040.351.122.301.391.790.64
Price To Earnings Ratio------3.65--
Price To Sales Ratio0.340.250.100.090.382.572.162.9961.22
Gross Margin52.8156.5055.6753.9757.9165.1362.9661.3728.87
Operating Margin-13.87-11.27-16.37-38.37-48.90-44.10-41.98-60.72-391.44
Net Margin-14.71-22.80-39.54-111.53-209.26-58.3429.21-213.21-89.76
Shares Outstanding11.128.920.490.370.170.160.140.080.02
Market Capitalization4.304.301.852.9613.66120.19104.26109.77106.45

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue5.555.645.024.724.614.755.114.56
Cost of Goods Sold Incl. D&A2.782.632.262.212.062.082.012.18
Gross Profit2.783.012.762.522.552.673.102.38
Selling, General and Administrative Excl. Other3.913.813.043.203.463.163.192.63
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-1.13-0.80-0.29-0.69-0.90-0.49-0.09-0.25
Interest Expense--0.00-----
Unusual Expense0.000.000.000.000.000.00-0.09-0.09
Net Income Before Taxes-1.13-0.80-0.28-0.68-0.90-0.480.02-0.15
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-1.13-0.80-0.28-0.68-0.90-0.480.02-0.15
Net Income From Continuing Operations-1.13-0.80-0.28-0.68-0.90-0.480.02-0.15
Net Income-1.20-0.88-0.32-0.68-1.23-1.48-0.99-1.16
EPS (Recurring)-0.11-0.08-0.04-0.08-0.21-1.90-1.84-2.48
EPS (Basic, Before Extraordinaries)-0.11-0.08-0.04-0.08-0.21-1.90-1.73-2.35
EPS (Diluted)-0.11-0.08-0.04-0.08-0.21-1.90-1.73-2.35
EBITDA-0.69-0.380.13-0.25-0.460.090.25-0.17
Non-Operating Income (Expense)0.000.000.000.010.010.010.010.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.070.300.000.010.000.000.000.03
Price To Sales Ratio0.340.390.640.560.270.070.090.10
Gross Margin50.0353.2954.9353.2855.3756.2960.6852.19
Operating Margin-20.36-14.20-5.71-14.53-19.64-10.23-1.69-5.46
Net Margin-21.58-15.55-6.47-14.40-26.67-31.19-19.27-25.36
Shares Outstanding11.1210.5010.078.928.910.780.690.49
Market Capitalization4.307.7912.1010.787.941.442.081.85

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments2.262.451.807.7227.4415.105.496.491.14
Short Term Receivables1.040.981.221.451.110.912.674.201.38
Inventories2.952.524.244.775.574.895.210.120.59
Other Current Assets0.300.430.822.082.372.812.290.940.09
Total Current Assets6.556.398.0716.0136.5023.7115.6511.763.20
Net Property, Plant & Equipment0.980.544.075.308.1810.031.720.050.14
Total Investments and Advances0.700.700.701.400.000.000.000.000.00
Intangible Assets2.122.893.2217.8379.6776.3076.303.173.24
Other Assets0.060.060.140.240.530.790.850.030.50
Total Assets10.4210.5816.2040.79124.88110.8494.5215.027.07
Short Term Debt Incl. Current Port. of LT Debt0.781.271.281.191.212.070.000.000.00
Accounts Payable1.171.541.912.042.982.853.020.480.47
Other Current Liabilities1.245.811.482.062.732.770.690.491.06
Total Current Liabilities3.198.624.675.296.927.693.710.971.52
Long Term Debt0.000.002.403.684.866.780.000.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities-----0.902.240.020.04
Other Liabilities0.000.000.090.409.9616.3050.960.010.36
Total Liabilities3.198.627.169.3721.7431.6656.911.001.92
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.010.010.010.010.000.000.000.00
Common Equity7.221.969.0331.42103.1479.1837.6012.614.21
Total Shareholders Equity7.231.969.0331.42103.1479.1837.6012.614.21
Accumulated Minority Interest0.000.000.000.000.000.000.001.410.94
Total Equity7.231.969.0331.42103.1479.1837.6014.025.15
Total Liabilities & Stockholders Equity10.4210.5816.2040.79124.88110.8494.5215.027.07
Book Value Per Share0.813.9824.39186.45642.56546.80488.36558.67194.42
Tangible Book Value Per Share0.57-1.8915.6980.62146.1719.86-502.60418.0244.85
Full-Time Employees42425290154165182711
Price to Book Ratio0.520.950.110.431.171.322.924.19-
Return on Assets-19.44-27.64-80.50-84.60-19.8512.32-82.95-16.27-40.00
Return on Equity-44.42-67.31-113.40-104.16-25.6621.67-180.95-21.37-76.01
Return on Invested Capital-28.24-188.45-200.60-199.64-21.6614.66-134.10-3.27-41.28
Quick Ratio1.130.450.822.134.472.452.8212.001.71
Current Ratio2.050.741.733.035.283.084.2212.132.10

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-2.89-2.04-3.70-22.94-70.08-23.3912.60-51.360.06
Depreciation1.711.801.822.932.972.251.900.290.22
Other Funds (Non Cash)1.130.761.9915.1454.919.44-25.5741.76-1.66
Funds from Operations-0.050.520.11-4.87-12.21-12.60-12.41-11.74-1.39
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-2.17-1.97-0.540.47-3.05-1.752.69-2.88-4.18
Cash from Operating Activities-2.22-1.45-0.43-4.41-15.25-14.35-9.73-14.62-5.57
Capital Expenditures-0.19-0.18-0.29-0.30-0.69-2.34-1.32-1.22-0.38
Net Assets From Acquisitions0.000.000.000.000.000.000.00-0.920.00
Sale of Fixed Assets and Businesses0.060.000.000.000.000.000.00--
Purchase or Sale of Investments0.000.000.001.000.00-0.21-0.250.00-0.30
Purchase of Investments0.000.000.000.000.00-0.75-0.250.00-0.30
Sale Or Maturity of Investments0.000.000.001.000.000.540.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-0.13-0.18-0.290.70-0.69-2.55-1.57-2.13-0.68
Cash Dividends Paid-0.120.000.00-3.67-4.00-2.55-0.370.000.00
Change in Capital Stock3.531.450.052.480.0030.9421.1918.6810.25
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock3.531.450.052.480.0030.9421.1918.6810.25
Proceedsfrom Stock Options3.531.450.052.480.0030.9421.1918.6810.25
Issuance or Reduction of Debt, Net0.000.001.25-0.13-0.03-0.151.49-0.760.00
Change in Long Term Debt0.000.000.00-0.13-0.03-0.151.49-0.760.00
Issuance of Long Term Debt0.000.000.000.000.000.001.490.000.00
Reduction of Long Term Debt0.000.000.00-0.13-0.03-0.150.00-0.760.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.060.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.000.00
Cash from Financing Activities3.411.451.30-1.32-4.0428.2322.3717.9210.25
Net Change in Cash1.06-0.190.58-5.03-19.9811.3311.071.174.00
Free Cash Flow-2.41-1.64-0.62-4.71-15.94-14.70-11.05-15.78-5.60
Preferred Dividends (Cash Flow)--0.00-3.67-4.00-2.55-0.370.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.00-0.90-1.35-2.42-0.02

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments2.122.643.392.261.061.77
Short Term Receivables1.751.571.121.040.971.05
Inventories3.473.653.142.953.182.88
Other Current Assets0.360.520.520.300.390.49
Total Current Assets7.708.388.176.555.606.19
Net Property, Plant & Equipment2.520.720.920.981.221.48
Total Investments and Advances0.700.700.700.700.700.70
Intangible Assets2.172.381.932.122.322.51
Other Assets0.060.060.060.060.060.06
Total Assets13.1512.2511.7810.429.9010.94
Short Term Debt Incl. Current Port. of LT Debt0.360.420.590.780.760.74
Accounts Payable1.491.390.881.171.221.29
Other Current Liabilities1.231.161.301.241.607.84
Total Current Liabilities3.082.972.773.193.589.87
Long Term Debt1.850.000.000.000.200.40
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.000.000.000.000.000.00
Total Liabilities4.932.972.773.193.7810.27
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.01
Common Equity8.219.289.017.226.110.66
Total Shareholders Equity8.219.289.017.236.110.67
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity8.219.289.017.236.110.67
Total Liabilities & Stockholders Equity13.1512.2511.7810.429.9010.94
Book Value Per Share0.740.880.890.810.690.84
Tangible Book Value Per Share0.540.660.700.570.43-2.36
Full-Time Employees---42--
Price to Book Ratio0.520.841.671.761.062.18
Return on Assets-25.07-22.91-20.06-19.44-12.75-1.25
Return on Equity-40.33-53.39-43.36-44.42-33.13-8.46
Return on Invested Capital-11.20-8.59-3.14-9.41-14.18-45.10
Quick Ratio1.371.591.811.130.670.34
Current Ratio2.502.822.942.051.560.63

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-1.13-0.80-0.28-0.68-0.90-0.48
Depreciation0.440.420.420.430.450.58
Other Funds (Non Cash)0.070.290.000.760.000.00
Funds from Operations-0.62-0.080.140.52-0.450.10
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital0.18-0.64-0.95-0.76-0.26-0.29
Cash from Operating Activities-0.44-0.72-0.81-0.24-0.70-0.19
Capital Expenditures-0.02-0.01-0.16-0.00-0.00-0.02
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.060.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.020.05-0.16-0.00-0.00-0.02
Cash Dividends Paid-0.120.000.000.000.000.00
Change in Capital Stock0.06-0.082.101.450.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.06-0.082.101.450.000.00
Proceedsfrom Stock Options0.06-0.082.101.450.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities-0.06-0.082.101.450.000.00
Net Change in Cash-0.52-0.751.131.20-0.71-0.20
Free Cash Flow-0.46-0.73-0.98-0.24-0.71-0.20

Revenue breakdown

Total Perfumes, Cosmetics & Other Toilet Preparations revenue2024: 19.48M 2025: 19.19M
United States2024: 19.48M 2025: 19.19M
Total Perfumes, Cosmetics & Other Toilet Preparations revenue2024: 19.48M 2025: 19.19M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-304.79%0.5M10.1M389.32K
2026-10-155.42%0.5M10.1M413.32K
2026-09-306.07%0.6M10.1M443.71K
2026-09-155.08%0.5M10.1M204.42K
2026-08-315.23%0.5M10.0M184.98K
2026-08-144.94%0.5M10.0M207.36K
2026-07-315.64%0.5M9.4M244.90K
2026-07-155.99%0.6M9.4M1.35M
2026-06-305.88%0.6M9.4M1.35M
2026-06-156.34%0.6M9.4M1.38M
2026-05-297.14%0.7M9.4M1.46M
2026-05-158.24%0.8M9.4M1.53M
2026-04-309.95%0.9M9.4M1.58M
2026-04-153.44%0.3M9.4M926.83K
2026-03-316.03%0.6M9.4M1.07M
2026-03-135.91%0.6M9.4M6.45M
2026-02-2711.75%1.1M9.4M11.24M
2026-02-1311.11%1.0M9.4M11.43M
2026-01-308.36%0.7M8.7M11.33M
2026-01-158.67%0.8M8.7M10.73M

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-04SCHEDULE 13DSEC
2026-11-043Initial statement of beneficial ownership of securities2026-10-30SEC
2026-11-048-KCurrent report2026-10-30SEC
2026-09-028-KCurrent report2026-09-01SEC
2026-08-1310-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-05-208-KCurrent report2026-05-20SEC
2026-05-1410-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-04-164Statement of changes in beneficial ownership of securities2026-04-14SEC
2026-04-164Statement of changes in beneficial ownership of securities2026-04-14SEC
2026-04-164Statement of changes in beneficial ownership of securities2026-04-14SEC
2026-04-164Statement of changes in beneficial ownership of securities2026-04-14SEC
2026-04-164Statement of changes in beneficial ownership of securities2026-04-14SEC
2026-04-164Statement of changes in beneficial ownership of securities2026-04-14SEC
2026-04-158-KCurrent report2026-04-14SEC
2026-04-018-KCurrent report2026-03-30SEC
2026-03-04EFFECTEffectiveness filing by commission orderSEC
2026-03-04424B4SEC
2026-03-02CORRESPSEC
2026-02-20S-1/ASEC
2026-02-1710-QQuarterly report pursuant to Section 13 or 15(d)2025-12-31SEC
2026-02-12DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-03-30SEC
2026-02-02PRE 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-03-30SEC
2026-01-30UPLOADUpload SubmissionSEC
2026-01-22S-1General form of registration statement for all companies including face-amount certificate companiesSEC
2026-01-2010-K/A2025-09-30SEC
2026-01-14424B3SEC
2026-01-148-KCurrent report2026-01-12SEC
2026-01-13EFFECTEffectiveness filing by commission orderSEC
2026-01-12CORRESPSEC
2026-01-12UPLOADUpload SubmissionSEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-12001.28M1
2025-110000

Institutional holders

Manager% owned
Worth Venture Partners, LLC1.76%
CSS LLC/IL1.31%
VANGUARD CAPITAL MANAGEMENT LLC1.14%
CHAPIN DAVIS, INC.0.73%
Alesco Advisors, LLC, An ESL Co0.65%
XTX Topco Ltd0.60%
JANE STREET GROUP, LLC0.52%
VANGUARD FIDUCIARY TRUST CO0.45%
Chicago Partners Investment Group LLC0.33%
UBS Group AG0.16%

Funds

Fund% owned
VANGUARD EXTENDED MARKET INDEX FUND1.14%
Fidelity Extended Market Index Fund0.01%
Blackstone Alternative Multi-Strategy Fund-0.02%

OakChart. YCBD. Cached 15 minutes.

Some panels did not load: ratings.